Scientists at AbboMax, Inc. Developed the New Panels of Monoclonal Antibodies to Study B- and T-Cell Lymphomas

Lymphoma is a malignant transformation of either B or T cells or their subtypes. All lymphoma subtypes combined are the seventh most common cancer in the United States. The B-cell lymphomas are types of lymphoma affecting B cells. About 85% of lymphomas are of B-cell origin. T-cell lymphomas are lymphomas that affect T cells. AbboMax has developed the new panels of monoclonal antibodies to study B- and T-cell lymphomas. - September 03, 2021

AbboMax Introduces a Panel of Monoclonal and Polyclonal Anti-Connexin Antibodies

AbboMax introduces a panel of monoclonal and polyclonal anti-connexin antibodies. There are 21 different types of connexins which are known to exist in humans and 20 types in mice. Their abnormal expression and function are associated with human hereditary diseases. AbboMax has been developing & manufacturing high performance immunoassay reagents for many years in California. - March 15, 2021

AbboMax is Pleased to Introduce the Collection of Monoclonal and Polyclonal Anti-STAT Antibodies

STAT proteins (Signal transducers and activators of transcription) are cytoplasmic transcription factors that play an essential role in transmitting signals from the cellular membrane to the nucleus. Misregulation of STAT pathway frequently leads to tumorogenesis. AbboMax introduces a panel of monoclonal and polyclonal anti-STAT antibodies. - February 27, 2021

14 New Monoclonal Anti-Cytokeratin Antibodies from AbboMax

AbboMax adds over a dozen new anti-cytokeratin monoclonal antibodies to its inventory. Cytokeratins are proteins found in epithelium. A variety of cytokeratins can be used for subtyping various forms of epithelial differentiation or for the detection of possible sites of origin of tumors. Primary tumors usually recapitulate the cytokeratin profiles of the cells from which they are derived. They are one of the most effective epithelial differentiation and tumor markers. - January 13, 2021

Scientists at AbboMax, Inc. Created a TBNK Panel of Monoclonal Antibodies to Study SARS-CoV-2

Understanding of a host immune response to SARS-CoV-2 is extremely important. It was previously shown that the immune system of patients infected by SARS-CoV-2 is severely impaired. In order to better recognize how immune response is orchestrated, the TBNK (B-Cell, T-Cell, and natural killer cells) panel of antibodies created by AbboMax, Inc. can be employed. - July 22, 2020

New NF-kB Panel of Antibodies from AbboMax and Human Diseases

NF-kB is a protein complex that controls the transcription of DNA. It is a heterodimer sequestered in the cytoplasm. In response to activation NF-kB translocates to the nucleus to 'turn on' the expression of specific genes that keeps a cell proliferating and protects it from apoptosis. AbboMax has developed a panel of NF-kB related antibodies. - December 22, 2019

Good News: a Panel of TGF-Beta and TGF-Beta Receptor Antibodies is Created by Abbomax

TGF-β regulates multiple biological processes, including embryonic development, adult stem cell differentiation, proliferation, homeostasis, immune regulation, wound healing, and inflammation. Multiple cells synthesize TGF-β and many cells have specific receptors for this peptide. AbboMax created a panel of TGF-β and TGF-β receptors antibodies. AbboMax, Inc. has been developing & manufacturing antibodies, FFPE cell pellets slides, for many years in California. - November 23, 2019

Scientists at AbboMax Developed Antibodies Against PINK1 and Parkin to Study Parkinson’s Disease

A panel of PINK1 and Parkin antibodies was developed at Abbomax to investigate Parkinson’s disease (PD). These phosphospecific and paired antibodies would be useful tools for studies of PINK/Parkin pathways and signaling in PD. AbboMax has been developing & manufacturing high performance immunoassay reagents for many years in California. AbboMax specializes in high-quality custom service and products focusing on antibody and assay development. - May 09, 2019

Panel of Six New Anti-Glutamate Receptor Antibodies from AbboMax and Their Function in the Central Nervous System and Other Organs

The neurotransmitter glutamate (Glu) is abundant in the human body, particularly in the nervous system. Glu binds to glutamate receptors (GluRs) leading to the activation of multiple signaling pathways. In addition to their fundamental role in neurotransmittion, GluRs contribute to the modulation of a variety of cellular functions such as the modulation of synaptic plasticity which is vital for memory and learning. Abbomax has developed a panel of six anti-GluR antibodies for the neuroscience. - January 15, 2014

Recent Progress in Neuroscience Research and the New Anti-GABAB1 Receptor Antibody from AbboMax, Inc.

Neurotransmitters are chemical messengers that transmit and modulate signals from neurons to other cells of the brain and body. GABA is the most prevalent inhibitory neurotransmitter in the mammalian central nervous system. GABA receptors are promising drug targets for a wide spectrum of psychiatric and neurological disorders. AbboMax, Inc. offers new anti-GABAB1 receptor polyclonal antibody as well as an extensive collection of neuroscience related antibodies. - December 19, 2013

Phosphorylation: One of the Hottest Topics in Cell Biology Research. Over 140 Phosphospecific Antibodies Are Developed in AbboMax, Inc.

Phosphorylation plays critical roles in the regulation of many cellular processes. This process is tightly associated with protein activity and is a key point of protein function regulation. The new phosphorus group alters the role of the protein: it can activate, deactivate, or cause a change in function. AbboMax, Inc. has developed over 140 phosphospecific antibodies. - November 20, 2013

Good News for Drug Delivery Researchers: AbboMax, Inc. Offers a Portfolio of Innovative Liposome Reagents

Liposomes are artificially-prepared vesicles that are made out of the same material as a cell membrane, a lipid bilayer. The liposomes can be filled with different substances and used as vehicles for drug or nutrient delivery. AbboMax offers various innovative liposome reagents with a large number of lipid compositions to support the needs of research organizations involved in liposome drug delivery. - October 16, 2013

AbboMax, Inc. Announces the Availability of a Portfolio of 23 Stem Cell Research Antibodies

Stem cell research is one of the most fascinating areas of modern biology. AbboMax offers 23 antibodies for stem cell research. Among them antibodies for FOX (Forkhead box) proteins, a family of transcription factors that play important roles in regulating the expression of genes involved in cell growth, proliferation, differentiation, and metabolism. Selected anti- FOXA-1,2,3 and Anti- FOXP-1,2,3 antibodies are validated for use in Western blot. - August 20, 2013

AbboMax Announces the Availability of New Mouse Anti-Desmoglein 3 (Dsg3) Monoclonal Antibody

Desmogleins are calcium-binding transmembrane glycoproteins, members of the desmosomal cadherins that provide adhesive integrity to desmosomes between adjoining keratinocytes. Desmoglein 3 protein has been identified as the autoantigen of the autoimmune skin blistering disease pemphigus vulgaris and plays important roles in human squamous cell cancer. - August 03, 2011

Press Releases 1 - 14 of 14